Endolymphatic radionuclide adjuvant therapy of melanoma and its side effects on the cellular immune system
Richter, G.; Heidenbluth, I.; Heidelbach, U.
Dermatologische Monatschrift 168(12): 797-806
1982
ISSN/ISBN: 0011-9083 PMID: 7169101 Document Number: 188176
Document emailed within 1 workday
Related Documents
Kubícek, J.; Vizda, J.; Urbanová, E.; Morávek, F. 1979: Endolymphatic radionuclide therapy Sbornik Vedeckych Praci Lekarske Fakulty Karlovy University V Hradci Kralove 22(2): 101-114Peters, P.E. 1974: Study group--endolymphatic radionuclide therapy Die Medizinische Welt 25(23): 1056-1058
Kubik, S. 1974: Anatomical prerequisites for endolymphatic radionuclide therapy Die Medizinische Welt 25(23): 1011-1016
Lohrmann, H.P. 1982: Significance of side-effects of adjuvant cytostatic therapy Aktuelle Probleme in Chirurgie und Orthopadie 22: 48-51
Uhlenbruck, G.; VAN Leendert, R.; Schneider, B.; Beuth, J. 2010: Reduced side-effects of adjuvant hormone therapy in breast cancer patients by complementary medicine In Vivo 24(5): 799-802
Chernukha, E.A.; Van'ko, L.V.; Chilingirov, R.Kh.; Naumov, I.G.; Matveeva, N.K.; Naumova, S.M.; Sukhikh, G.T. 1994: Evaluation of the effects of methods of suppurative-inflammatory complications prevention after cesarean section on cellular and humoral components of the immune system Akusherstvo i Ginekologiia 1994(6): 33-37
Chang, Y.H. 1977: Adjuvant polyarthritis I: incorporation of quantitative measurements of humoral and cellular immune response Journal of Pharmacology and Experimental Therapeutics 201(1): 1-7
Postow, M.A. 2018: Does adjuvant therapy for high-risk melanoma with either immunotherapy or targeted therapy affect therapeutic choices at relapse? Clinical Advances in Hematology and Oncology: H&o 16(5): 353-355
Maghnie, M.; Valtorta, A.; Moretta, A.; Priora, C.; Preti, P. 1990: Effects of chorionic gonadotropin (hCG) therapy on the immune system Medicina 10(2): 148-149
Eggermont, A.M. 2001: Frontiers in adjuvant therapy in stage II-IIi melanoma Tumori 87(4): S60-S63
Schreml, W. 1982: Malignant melanoma - adjuvant systemic therapy Aktuelle Probleme in Chirurgie und Orthopadie 22: 64-65
Xu, K.; Xu, S.-H.; Feng, X.; Yu, S.-Q.; Zeng, Y. 2014: IL15 DNA adjuvant enhances cellular and humoral immune responses induced by DNA and adenoviral vectors encoding HIV-1 subtype B gp160 gene Bing du Xue Bao 30(1): 62-65
Morton, D.L. 2004: Immune response to postsurgical adjuvant active immunotherapy with Canvaxin polyvalent cancer vaccine: correlations with clinical course of patients with metastatic melanoma Developments in Biologicals 116: 209
Agarwala, S.S.; Kirkwood, J.M. 2002: Update on adjuvant interferon therapy for high-risk melanoma Oncology 16(9): 1177-87; Discussion 1190-2 1197
Zola, H. 1974: Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen Clinical and Experimental Immunology 16(3): 469-479
Thatcher, N.; Swindell, R.; Crowther, D. 1979: Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly sequential study of melanoma patients. I. Changes in non-specific (NK, K and T cell) lymphocytotoxicity, peripheral blood counts and delayed hypersensitivity reactions Clinical and Experimental Immunology 36(2): 227-236
Johnson, D.M.; Hayat, S.Q.; Burton, G.V. 1999: Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma Journal of Rheumatology 26(4): 1009-1010
McMasters, K.M.; Sober, A.; Kirkwood, J.M. 2003: Sentinel lymph node biopsy and adjuvant therapy for melanoma: evidence revisited Archives of Dermatology 139(1): 99; Author Reply 99-100
Tricarico, M.; Nunziata, C.; Atzori, F.; Concolino, F.; Macchini, V.; D'Atri, S.; Prete, S.P.; Turriziani, M.; Lanzilli, G.; Sera, F.; Abeni, D.; Albanesi, V.; Bonmassar, E.; Pagani, E. 2004: Adjuvant therapy of melanoma patients (stage II, III): a pilot immuno-toxicological study Journal of Experimental and Clinical Cancer Research: Cr 23(4): 573-578
Hartmann, D.W.; Robinson, W.A.; Mangalik, A.; Glode, L.M.; Triebel, F. 1981: Unanticipated side effects from treatment with high-dose mechlorethamine in patients with malignant melanoma Cancer Treatment Reports 65(3-4): 327-328